IE00BQ70R696
IE00BQ70R696
Invesco NASDAQ Biotech UCITS ETF Acc
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Synthetic Replication Note (Swap ETF)
Synthetic (Swap)The reported holdings, valuation ratios (P/E, etc.), and analyst estimates reflect the fund's underlying collateral/substitute basket, not the actual composition of the tracked index.
This ETF replicates index returns using financial derivatives (total return swaps) with counterparty banks. For regulatory reasons, the fund maintains a physical collateral basket which often consists of completely different securities than the benchmark index. While price performance accurately tracks the benchmark, fundamentals, sector weights, and individual holdings represent this collateral basket.
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
18.06
Weighted Fwd P/E
59.17
Avg P/FCF
29.01
Avg FCF Yield
0.82%
Avg EV / EBITDA
48.43
Avg EV / Revenue
104.3
Avg Price-to-Book (P/B)
17.36
Avg Price-to-Sales (P/S)
122.78
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
+227.66%
Avg Debt-to-Equity (D/E)
147.64%
<50% (53.71%) 50-150% (13.97%) >150% (23.81%) Unreported (8.51%)
Profitability Analysis
246 Holdings CountProfitable 66.18%
Profitable 66.18%
85
Holdings Count (34.55%)
Unprofitable 33.82%
161
Holdings Count (65.45%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
33.0%
Top 10
44.4%
Top 25
63.7%
50% Threshold
Top 14
The top 10 positions account for 44.4% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
16 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (22.0%+)
High (57.1%+)
Top (79.1%+)
Country Breakdown
Max: 87.91%87.91%
2.50%
2.20%
1.70%
1.42%
1.25%
1.13%
0.76%
0.74%
0.11%
0.06%
0.05%
0.05%
0.03%
0.03%
0.01%
Sector Distribution
2 SectorHealthcare
99.96%
Unknown
0.04%
Industry Distribution
8 IndustriesBiotechnology
67.63%
Drug Manufacturers - General
18.58%
Drug Manufacturers - Specialty & Generic
6.74%
Diagnostics & Research
5.51%
Health Information Services
0.69%
Medical Devices
0.68%
Medical Care Facilities
0.13%
Unknown
0.04%
Market Cap Distribution
246 Holdings CountMega Cap (> 200B)
(1) 8.06%
Large Cap (10B - 200B)
(29) 58.69%
Mid Cap (2B - 10B)
(66) 23.71%
Small / Micro Cap (< 2B)
(150) 9.54%